Navigation Links
Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs
Date:11/5/2008

laborative partners; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements.

Contacts: Alan R. Engbring

Executive Director, Investor Relations

(858) 646-1127

Website: http://www.vical.com

Jill M. Church

Vice President and Chief Financial Officer

VICAL INCORPORATED

Selected Condensed Financial Information (Unaudited)

Statements of Operations Three Months Ended Nine Months Ended

(in thousands, except per Sept. 30, Sept. 30,

share amounts) 2008 2007 2008 2007

Revenues:

Contract and grant revenue $711 $164 $1,604 $3,994

License and royalty revenue 133 211 3,727 747

Total revenues 844 375 5,331 4,741

Operating expenses:

Research and development 6,226 5,580 19,284 17,314

Manufacturing and production 2,716 2,871 8,772 11,034

General and administrative 2,087 2,192 6,439 6,825

Total operating expenses 11,029 10,643 34,495 35,173

Loss from operations (10,185) (10,268) (29,164) (30,432)

Net investment income 360 1,029 1,292 3,399

Net loss $(9,825) $(9,239) $(27,872) $(27,033)

Basic and diluted net loss

per share $(0.24) $(0.24) $(0.70) $(0.69)

Weighted average shares use
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vical Announces News Release and Conference Call Schedule For Third Quarter 2008 Financial Results
2. Vical to Present at Upcoming Investor Conferences
3. Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
4. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
5. Vical to Present at UBS Global Life Sciences Conference
6. Society of Gynecologic Oncologists to Host Cervical Cancer Prevention Forum
7. Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
8. Vical to Present at Upcoming Investor Conferences
9. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
10. Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results
11. One4One Campaign to Raise $1 Million to Improve Cervical Cancer Education and Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... to progressing its ground-breaking technology platforms to Phase 1 ... the Company delivers the best value for shareholders. ... said the Company currently had an extensive program of ... and academic partnerships and initiatives, and he was working ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
(Date:7/29/2015)... July 29, 2015  AsureQuality and Ubiquitome have ... for applications in food and primary production sectors. ... real-time PCR device, the Freedom4. AsureQuality ... to the supermarket shelf for producers, processors and ... in animal disease control and pest management and ...
(Date:7/29/2015)... -- Research and Markets ( ... "Global Biosimilars Market, 2015 - 2025" ... Biosimilars Market, 2015 - 2025, report provides an ... With the blockbuster biologics losing patent protection and ... being viewed as viable substitutes to the highly ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3
... Stallergenes,has been granted with the marketing authorisation for ... PEI (Paul Ehrlich,Institute), the biological branch of the ... results of the paediatric pivotal study (VO52),Stallergenes will ... indications., Stallergenes will launch Oralair(R) Grasses in ...
... Clinical Trial Capability into the Frontage ... ... Frontage Laboratories,( http://www.frontagelab.com ) (Malvern and Exton, PA USA ... pre-clinical and,drug development services to the pharmaceutical industry, announced today,it ...
... for Thursday, June 26th at 2:30pm ET, NEW ... ) today announced that Michael S. Weiss, the Company,s,Chairman ... the,Jefferies & Co. Healthcare Conference being held in New ... live on Thursday, June 26th at,2:30pm ET and will ...
Cached Biology Technology:Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany 2Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 2Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 3Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR) 4Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference 2
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... July 30, 2015 after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3
... microbial communities and the growth of sedimentary rock at ... a surprising discovery about the geological record of life ... sequences of sedimentary rock are dated, and how scientists ... We found microbes change the rate at which calcium ...
... a combination of individual scientific skills, expertise and ... offer the opportunity to build a highly focused ... the urgent need for bringing new antibiotic compounds ... and other antimicrobial agents have saved millions of ...
... Assessment of Climate Change for the Baltic Sea Basin (BACC), ... of past and possible future climate change in the region, ... northern and mid-Europe. One of the key findings is that ... up to five degrees Celsius from now to 2100. More ...
Cached Biology News:Hot springs microbes hold key to dating sedimentary rocks, researchers say 2Unique fungal collection could hold key to future antibiotics 2Unique fungal collection could hold key to future antibiotics 3Climate change in the Baltic Sea basin -- past, present and future 2Climate change in the Baltic Sea basin -- past, present and future 3
... Raji cells were cultured in RPMI 1640 medium ... log phase of growth. In order to ... were fixed in acetone-methanol. The cells are ... slide, with each wells surface specifically treated to ...
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... trays are disposable trays that ... that have been blotted onto ... eight 10.5 cm x 5 ... cut from blotted membrane and ...
... the state-of-the-art in permanent mounting media. ... preservation of immunohistochemical organic insoluble substrates ... New Fuchsin, and any other organic ... sections. Clarin can be used for ...
Biology Products: